CAMBRIDGE, MASSACHUSETTS, April 28, 2021 - Paragonix Technologies announced the presentation of the First Report of the GUARDIAN Registry1 at the International Society for Heart and Lung Transplantation 2021 Annual Meeting. The GUARDIAN study is the…
CAMBRIDGE, MASSACHUSETTS, MARCH 12, 2021 - Paragonix Technologies, Inc. announced today that Lisa Anderson, Ph.D., has been elevated to the role of CEO. Dr. Anderson succeeds William Edelman, who has served…
CAMBRIDGE, MASSACHUSETTS, February 22, 2021 - Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-man clinical use of the only FDA cleared cold storage device for donor…
LUNGguard™ Donor Lung Preservation System delivers advanced lung preservation to transplant teams at a critical moment CAMBRIDGE, MASSACHUSETTS, January 6, 2020- Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider,…
Paragonix to Participate in 23rd Annual Needham Growth Conference in 2021 CAMBRIDGE, MASSACHUSETTS, January 4, 2020 -- Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today that Bill…
CONTACT
Paragonix Technologies, Inc
222 Third Street
Suite 2242
Cambridge, Massachusetts 02142
info@paragonixtechnologies.com
© 2022 All Rights Reserved | L-294